astragaloside a has been researched along with Cardiac Failure in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (8.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (33.33) | 24.3611 |
| 2020's | 7 (58.33) | 2.80 |
| Authors | Studies |
|---|---|
| Feng, W; Li, Y; Sun, H; Xue, Y; Yang, J; Zhang, J | 1 |
| Chen, W; Fan, X; Gao, S; Huang, C; Jiao, G; Qiu, S; Sun, M; Tao, X; Weng, N; Zhang, F; Zhou, X | 1 |
| Chen, L; Chen, Y; Jiang, Y; Kong, M; Li, J; Wang, Q; Wei, N; Xu, L; Yuan, C | 1 |
| Cui, XY; Li, D; Li, XX; Li, Y; Lin, Q; Liu, J; Lu, JJ; Wu, Y; Zhou, K | 1 |
| Duan, DD; Jin, G; Liu, X; Luan, X; Sun, Q; Tian, S; Wan, J; Wang, P; Wu, C; Yang, Y; Ye, LL; Zang, Y; Zhan, X; Zhang, W; Zhang, Z | 1 |
| Huang, S; Liu, X; Wan, J; Zang, Y; Zhang, W; Zhang, Z | 1 |
| Liu, L; Liu, Y; Ren, YK; Sui, YB; Zhang, KK | 1 |
| Cao, T; Chen, H; Dong, Z; Guo, W; Lu, R; Tian, J; Wei, H; Xu, M; Zhang, C; Zhao, P | 1 |
| Tan, HY; Tang, B; Wei, XQ; Zhang, JG | 1 |
| Guo, Y; Ji, Y; Li, L; Wang, T; Wang, Y; Yang, B; Zhang, X; Zhu, T | 1 |
| Liu, F; Liu, L; Sui, YB; Wang, Y; Zhang, YQ | 1 |
| Dai, RH; Li, Y; Luo, HM | 1 |
2 review(s) available for astragaloside a and Cardiac Failure
| Article | Year |
|---|---|
Astragaloside IV for Heart Failure: Preclinical Evidence and Possible Mechanisms, A Systematic Review and Meta-Analysis.
Topics: Animals; Heart Failure; Mice; Natriuretic Peptide, Brain; Rats; Stroke Volume; Ventricular Function, Left | 2023 |
An updated role of astragaloside IV in heart failure.
Topics: Cardiovascular Agents; Drugs, Chinese Herbal; Heart Failure; Humans; Saponins; Triterpenes | 2020 |
1 trial(s) available for astragaloside a and Cardiac Failure
| Article | Year |
|---|---|
[Nuclear cardiology study on effective ingredients of Astragalus membranaceus in treating heart failure].
Topics: Adolescent; Adult; Aged; Astragalus propinquus; Cardiotonic Agents; Drugs, Chinese Herbal; Female; Gated Blood-Pool Imaging; Glucosides; Heart Failure; Humans; Injections, Intravenous; Male; Middle Aged; Saponins; Single-Blind Method; Triterpenes; Ventricular Function, Left | 1995 |
9 other study(ies) available for astragaloside a and Cardiac Failure
| Article | Year |
|---|---|
Astragaloside IV alleviates heart failure by modulating Nrf-2.
Topics: Heart Failure; Humans; Saponins; Triterpenes | 2022 |
Evaluation of the effect of Shengxian Decoction on doxorubicin-induced chronic heart failure model rats and a multicomponent comparative pharmacokinetic study after oral administration in normal and model rats.
Topics: Animals; Astragalus propinquus; Cardiovascular Agents; Chromatography, High Pressure Liquid; Chronic Disease; Drugs, Chinese Herbal; Electrocardiography; Heart Failure; Male; Mass Spectrometry; Medicine, Chinese Traditional; Rats; Rats, Sprague-Dawley; Saponins; Triterpenes | 2021 |
Comparative pharmacokinetics of seven bioactive components after oral administration of crude and processed Qixue Shuangbu Prescription in chronic heart failure rats by microdialysis combined with UPLC-MS/MS.
Topics: Administration, Oral; Animals; Chromatography, High Pressure Liquid; Chromatography, Liquid; Drugs, Chinese Herbal; Heart Failure; Microdialysis; Prescriptions; Rats; Rats, Sprague-Dawley; Tandem Mass Spectrometry | 2023 |
Astragaloside IV derivative HHQ16 ameliorates infarction-induced hypertrophy and heart failure through degradation of lncRNA4012/9456.
Topics: Animals; Cardiomegaly; Heart Failure; Humans; Mice; Myocardial Infarction; Myocytes, Cardiac | 2023 |
The role of Nrf2 in astragaloside IV-mediated antioxidative protection on heart failure.
Topics: Animals; Antioxidants; Cardiotonic Agents; Cell Line; Echocardiography; Heart Failure; Heme Oxygenase-1; Male; Myocardial Infarction; Myocytes, Cardiac; NF-E2-Related Factor 2; Oxidative Stress; Rats; Rats, Sprague-Dawley; Saponins; Signal Transduction; Stroke Volume; Survival Analysis; Transcriptional Activation; Triterpenes | 2020 |
Astragaloside IV alleviates heart failure via activating PPARα to switch glycolysis to fatty acid β-oxidation.
Topics: Animals; Apoptosis Regulatory Proteins; Calcium; Cardiotonic Agents; Cell Respiration; Disease Models, Animal; Energy Metabolism; Enzyme Activation; Fatty Acids; Gene Expression Regulation; Glucose; Glycolysis; Heart Failure; Heart Function Tests; Hemodynamics; Male; Mice; Mitochondria, Heart; Oxidation-Reduction; PPAR alpha; Saponins; Triterpenes | 2017 |
Astragaloside IV inhibits ventricular remodeling and improves fatty acid utilization in rats with chronic heart failure.
Topics: Animals; Benzazepines; Chronic Disease; Chymases; Disease Models, Animal; Energy Metabolism; Fatty Acids; Heart Failure; Heart Ventricles; Humans; Myocardium; Myocytes, Cardiac; PPAR alpha; Rats; RNA, Messenger; Saponins; Triterpenes; Ventricular Remodeling | 2018 |
Astragalosides increase the cardiac diastolic function and regulate the "Calcium sensing receptor-protein kinase C-protein phosphatase 1" pathway in rats with heart failure.
Topics: Animals; Animals, Newborn; Blood Pressure; Cells, Cultured; Diastole; Dose-Response Relationship, Drug; Drugs, Chinese Herbal; Heart Failure; Male; Protein Kinase C-alpha; Protein Phosphatase 1; Random Allocation; Rats; Rats, Wistar; Receptors, Calcium-Sensing; Saponins; Triterpenes | 2018 |
Astragaloside IV alleviates heart failure by promoting angiogenesis through the JAK-STAT3 pathway.
Topics: Angiogenesis Inducing Agents; Animals; Coronary Vessels; Disease Models, Animal; Heart Failure; Human Umbilical Vein Endothelial Cells; Humans; Janus Kinases; Kaplan-Meier Estimate; Male; Myocardial Infarction; Myocardium; Platelet Endothelial Cell Adhesion Molecule-1; Random Allocation; Rats; Rats, Sprague-Dawley; Saponins; Signal Transduction; STAT3 Transcription Factor; Triterpenes; Weight Gain | 2019 |